$ANL - Back down to the cost basis for Balyasny, Point72, Squadron etc and the $55m personal investment from CEO, Yang Lu.
Downside right now looks like 20-25% to me if we break this current channel. Upside is ~100% to previous highs which many think is still an undervaluation.
$BRZU - @RenanSantosMBL wins in October 🇧🇷
Fascinating parallels to Biden (@LulaOficial is 80), Jair similar to Trump, @JMilei, Jan 6th (literally Jan 8th, 2 years later)
Long Renan (@Kalshi), long IBOVESPA, long Haddad (2% > 40% on Lula dropout)
https://t.co/wLj5h50Wj1
$TRAW - Moved on its PR about advancing hantavirus antiviral candidates. @OrbiMed also added 598k shares @ $1.67 on 4/16, basically 2x of their prior common share stake. Also bought ~$5m in warrants at $1.673 apiece.
Other big funds: Adage (add), ADAR1, Squadron & Ikarian (add)
Squadron Capital Management - Check out those returns, and they're fresh off a massive win on $rlmd
So, what's next??? $TRAW.
On sept. 12th, Squadron bought 5.3% of $TRAW bringing their total to 6.0% (of ~7.1m shares OS)
Mcap is ~$16m & Cash on 6/30 was $13.1m (1 year of ops)
@PickingMyOwn@seedy19tron Panther, any idea what's happening with that secondary offering? Don't they have to announce it's closing and what funds bought in?
$CTMX - Earnings tomorrow! Don't have a view, but we may get clarity on the March 16th $5.3 secondary with no closing PR? There were insider sales filed 3/19 but all were for RSU tax reasons or planned via Rule 10b5-1.
Chart is Do or Die bouncing off channel bottom in past week.
$CTMX ($4.45) - Nice setup. Sell-side has PTs of $11-17 from after 3/16 data.
Holders STRONG & added: VR Adviser, LLC (unsure), Perceptive, Kynam, Commodore, BBs, ADAR1, Ikarian, Orbimed
$ctmx did $250m ATM ($5.3/sh) on 3/17. Shares went $7-8 down to $4
ST PT is $6.90+ (57%+)
2/2 -
2. Sell to SMB vs sell to enterprise
-Tough to do both of these things or expand from one to other
-Typically companies do acquisitions within these ‘weight classes’
$FRSH does both via @freshdesk@device42 FireHydrant etc. @StayGoldSF
1/2 - From a KOL (5/5/2026):
"A software company can typically be bucketed in certain ways, and M&A is related to that.
1. Great at 1 thing vs. Ok at many things
-Great at 1 thing —> buy smth to become better
-Ok at many things —> buy another thing
$FRSH maps to 2nd category
$AAPL - Interesting excerpt from @TrungTPhan's piece on @Apple
The "low cost of labor" in China narrative I grew up with may just be counterfactual negative propaganda
Rather, advanced tooling engineers draw manufacturers as other countries deemphasize vocational education
@JoseRestonVA Yes, I haven’t been able to figure out the secondary closing mystery either. I’m relatively new to biotech but don’t remember another instance like this? Do you?
Would love to know who got in, if it was upsized etc.
$NKTR - Support is coming. Looks like ~$81 will be roughly the bottom. Could test the channel for a few days, but r/r here is great.
Upside is + ~34% back to $109 previous '26 high then ~$125 over next few months
$LULU - WHAT are they DOING...😖 didn't listen to @ChipYVR
1. Any $NKE exec probably shouldn't have been considered
2. She was #2 on Donahoe's disastrous DTC strategy & got FIRED by Elliott Hill
3. Her experience (@Nike + @LEVIS) is all at legacy brands
ST TA PT: $124 (-20%)